Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
3
×
new york blog main
san francisco blog main
boston
fda
national
new york top stories
san diego blog main
san francisco top stories
acute myeloid leukemia
alx oncology
antibiotics
arvinas
astellas pharma
astrazeneca
atlas venture
audentes therapeutics
autoimmune diseases
avidity biosciences
berkeley lights
biotech ipos
bluebird bio
boulder/denver
boulder/denver blog main
boulder/denver top stories
cancer drugs
cancer immunotherapy
carbapenem-resistant enterobacteriaceae
cd47
celgene
chronic kidney disease
deals
deerfield healthcare technology acquisitions
deerfield management company
What
ipo
3
×
ipos
3
×
biotechs
life
science
week
ago
arrival
biotech
chose
close
companies
company
considering
data
days
device
diseases
drug
dyne
early
expected
experimental
eyes
firms
genetic
hasn’t
having
humans
industry
long
make
market
medical
medicines
momentum
muscle
new
open
q
Language
unset
Current search:
ipo
×
ipos
×
" national top stories "
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way